Evidence map›Paper›PMID 42451335›Full record

ArticleSensors (Basel, Switzerland)2026

Exploring the Potential of Site-Selective Labeling on a Green Fluorescent Protein Through Lys-His Linchpin-Directed Modification.

Stefania Bova, Marialaura Marchetti, Ilaria De Nardis, Serena Faggiano, Samanta Raboni, Alessandra Gritti, Elisa Pianta, Valentina Pirovano, Giorgio Abbiati, Gloria Modafferi and 5 more

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Stefania BovaBiopharmanet_TEC, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy.ORCID 0000-0001-9786-2413
Marialaura MarchettiDepartment of Medicine and Surgery, University of Parma, Via Volturno, 39, 43125 Parma, Italy.ORCID 0000-0002-4615-6786
Ilaria De NardisBiopharmanet_TEC, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy.
Serena FaggianoDepartment of Food and Drug, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy.ORCID 0000-0002-7447-9945
Samanta RaboniDepartment of Food and Drug, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy.ORCID 0000-0003-3068-3714
Alessandra GrittiDepartment of Pharmaceutical Sciences, General and Organic Chemistry Section "A. Marchesini", University of Milan, Via Golgi 19, 20133 Milano, Italy.
Elisa PiantaDepartment of Pharmaceutical Sciences, General and Organic Chemistry Section "A. Marchesini", University of Milan, Via Golgi 19, 20133 Milano, Italy.ORCID 0009-0007-9889-5867
Valentina PirovanoDepartment of Pharmaceutical Sciences, General and Organic Chemistry Section "A. Marchesini", University of Milan, Via Golgi 19, 20133 Milano, Italy.ORCID 0000-0003-3113-6579
Giorgio AbbiatiDepartment of Pharmaceutical Sciences, General and Organic Chemistry Section "A. Marchesini", University of Milan, Via Golgi 19, 20133 Milano, Italy.ORCID 0000-0002-2502-4127
Gloria ModafferiChiesi Farmaceutici S.p.A., Global Research and Preclinical Development Area, Largo Belloli, 11/A, 43122 Parma, Italy.
Barbara PioselliChiesi Farmaceutici S.p.A., Global Research and Preclinical Development Area, Largo Belloli, 11/A, 43122 Parma, Italy.
Stefano BrunoBiopharmanet_TEC, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy.
Barbara CampaniniBiopharmanet_TEC, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy.ORCID 0000-0003-0359-0627
Stefano BettatiBiopharmanet_TEC, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy.ORCID 0000-0001-6787-0594
Luca RondaBiopharmanet_TEC, University of Parma, Parco Area delle Scienze, 27/A, 43124 Parma, Italy.ORCID 0000-0002-5389-2669

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein-based biosensors require controlled and site-selective functionalization strategies to enable stable and oriented immobilization without compromising protein structure and signal transduction efficiency. We evaluated a chemoselective linchpin-directed modification (LDM) approach targeting Lys-His pairs as a tool for site-specific labeling of the model fluorescent biosensor green fluorescent protein (GFP). LDM molecules with variable spacer lengths were prepared, and a structure-guided computational workflow was implemented to map Lys-His distances on the protein and identify candidate modification sites. Experimental validation by UV-Vis spectroscopy and mass spectrometry demonstrated efficient conjugation and a final degree of labeling close to unity, consistent with single-site modification, with all LDM molecules selectively targeting the same histidine residue (His181), independently of spacer length. Structural analysis revealed that this residue is located within an accessible internal cavity that favors productive interactions with the reactive group. Importantly, the modification preserves GFP fluorescence and pH response, confirming retention of sensing functionality. These results demonstrate that LDM enables selective modification not only of surface residues, but also of structurally guided, non-surface residues. This approach provides the proof of concept of a new, promising strategy for the controlled functionalization and immobilization of protein-based biosensors.

Indexed as

Biosensing TechniquesGreen Fluorescent ProteinsHistidineLysineHydrogen-Ion ConcentrationModels, MolecularStaining and LabelingGreen Fluorescent ProteinsHistidineLysinegreen fluorescent protein (GFP)linchpin-directed modification (LDM)protein biosensorssite-selective labeling

Identifiers

PMID42451335
PMCPMC13364192

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.